Last Updated: October 26, 2026
Quick Summary
Treating co-occurring anxiety and substance use works best as one integrated plan, not two separate ones. Cognitive behavioral therapy addresses both conditions at once, and integrated care outperformed substance-use treatment alone on both substance-use and anxiety outcomes. Start with a dual-diagnosis assessment that separates anxiety symptoms from withdrawal.
- About 21.2 million U.S. adults had a co-occurring mental illness and substance use disorder, per the 2024 National Survey on Drug Use and Health.
- A 2023 review found integrated behavioral treatments outperformed substance-use-disorder treatment alone, with small-to-moderate effects.
- Intensive outpatient programs sit between weekly therapy and residential care, letting people keep living at home.
- Benzodiazepines carry dependence and misuse risk, making them complicated for anyone with a substance use disorder.
- Bring a written timeline to your first appointment showing when anxiety and substance use started and which came first.
Table of Contents
- Why Co-Occurring Anxiety and Substance Use Need One Treatment Plan
- Evidence-Based Therapies for Anxiety and Addiction
- Intensive Outpatient Programs for Co-Occurring Disorders
- How Long Is Treatment for Co-Occurring Disorders?
- Medication, Screening, and the Assessment That Shapes Care
- Family Support, PAWS, and Digital Tools That Keep Recovery Moving
- Verify Your Insurance and Start With a Clinical Assessment
- Frequently Asked Questions
Why Co-Occurring Anxiety and Substance Use Need One Treatment Plan
Approximately 21.2 million adults in the United States had a co-occurring mental illness and substance use disorder, according to the 2024 National Survey on Drug Use and Health from SAMHSA’s co-occurring disorders overview. That figure explains why treating co-occurring anxiety and substance use as two separate problems so often fails.
Co-occurring anxiety and substance use means a person meets criteria for an anxiety disorder and a substance use disorder at the same time. At Utah Family Therapy, we treat the anxiety and the substance use as one clinical picture.
Here is the core argument: split treatment is the default in most of the health system.
How Anxiety and Substance Use Reinforce Each Other
Anxiety and substance use reinforce each other through a loop that gets tighter with repetition. A person feels rising fear or panic, drinks or uses to blunt it, and gets short-term relief.
A review of co-occurring anxiety and substance use disorder treatment by R.
That is the practical problem. Anxiety symptoms and withdrawal symptoms look alike, so a clinician working on one condition alone can miss the other entirely.
Evidence-Based Therapies for Anxiety and Addiction
Cognitive behavioral therapy is the most studied psychosocial treatment for co-occurring anxiety and substance use, and it works on both conditions at once.
A 2023 review of integrated behavioral treatments found that integrated care outperformed substance-use-disorder treatment alone on both substance-use and anxiety outcomes, with small-to-moderate effects favoring the integrated approach.
For readers who want to understand the anxiety side in more depth, we explain what anxiety disorders are and how they are diagnosed.
Cognitive Behavioral Therapy and Motivational Interviewing
CBT and motivational interviewing do different jobs, which is why good programs use both. CBT restructures the fear-driven thinking and builds exposure-based coping skills.
Contingency management adds a third piece: structured, tangible reinforcement for verified abstinence. It has strong support in the addiction literature, and it pairs well with CBT because it rewards the behavior change CBT is trying to build.
Other evidence-based components we draw on include:
- Cognitive behavioral therapy for fear extinction and emotional reactivity
- Motivational interviewing to build readiness rather than force it
- Contingency management for early abstinence reinforcement
Our clinicians deliver these approaches through anxiety treatment grounded in CBT and Brainspotting, matched to what the assessment actually shows.
Intensive Outpatient Programs for Co-Occurring Disorders
Intensive outpatient programs for co-occurring disorders deliver several structured treatment hours per week while the person keeps living at home.
That middle tier matters for dual diagnosis care.
Utah Family Therapy runs IOPs for teens and adults, in person and online, and our clinicians combine professional training with lived experience of recovery. If you want a concrete picture before committing, read what a real IOP session feels like.
Best for: people who need several treatment contacts per week but can stay at home. Skip if: someone is in acute withdrawal or at immediate risk, which needs a higher level of care first.
How Long Is Treatment for Co-Occurring Disorders?
There is no single answer, because treatment length for co-occurring disorders depends on severity, substance type, support at home, and how long the anxiety went untreated.
What we can say with confidence: anxiety treatment that stops when the substance stops is incomplete.
If the time commitment is the worry, we answer the question families ask most: can I keep my job while attending IOP.
Medication, Screening, and the Assessment That Shapes Care
Screening comes first, and it shapes everything after it. A proper psychiatric evaluation separates anxiety symptoms from withdrawal symptoms, checks for other comorbidity, and identifies anything that changes the level of care. Skipping that step is how people end up treated for half their problem.
What a Real Assessment Looks Like
A dual-diagnosis assessment is not a single questionnaire. Most clinicians combine a structured interview with validated screening tools, then cross-check the timeline of symptoms against the timeline of substance use. The order matters: anxiety that predates the first drink points one direction; anxiety that only appears during withdrawal points another.
A good assessment asks about trauma history, sleep, prescription medication use, and family history. Those details change the treatment plan more than any single score does.
VERIFY INSURANCE & GET STARTED →
Medication Decisions in Co-Occurring Cases
Medication decisions belong to a prescriber, and the details matter in co-occurring cases. Benzodiazepines carry dependence and misuse risk, which makes them a complicated choice for anyone with a substance use disorder.
Medication-assisted treatment (MAT) is the standard of care for opioid use disorder and has strong support for alcohol use disorder.
We do not recommend specific medications here; that conversation belongs in a clinical assessment with a prescriber who knows your history.
Why Integrated Assessment Beats Sequential Assessment
SAMHSA describes its resources as evidence-based support for providers screening, diagnosing, and delivering integrated care to people with co-occurring disorders, per SAMHSA’s co-occurring disorders resource page.
The practical difference: in a sequential model, you finish substance treatment, then get referred for anxiety, then wait weeks for an opening.
A dual-diagnosis assessment draws on several validated screening tools, each aimed at a different part of the picture.
|
Tool |
What it screens |
Note |
|---|---|---|
|
GAD-7 |
Generalized anxiety severity |
Seven-item screen used in primary care |
|
AUDIT |
Hazardous drinking patterns |
Alcohol Use Disorders Identification Test |
|
DAST-10 |
Drug use |
Drug use screening |
|
COWS |
Opioid withdrawal |
Clinical Opiate Withdrawal Scale |
|
CIWA-Ar |
Alcohol withdrawal |
Clinical Institute Withdrawal Assessment for Alcohol |
|
PHQ-9 |
Depression |
Used when depression may accompany anxiety |
Family Support, PAWS, and Digital Tools That Keep Recovery Moving
Most treatment guides stop at the clinic door. The three forces below determine whether recovery holds between sessions.
Family and Caregiver Support Without Enabling
Family and caregiver support changes outcomes, and the line between support and enabling is thinner than most families expect.
A useful frame for caregivers:
- Support looks like attending appointments with permission, asking what help is wanted, and learning the difference between a bad day and a warning sign.
- Enabling looks like paying off consequences, making excuses to employers or schools, or keeping secrets from other family members.
- The gray zone is money, transportation, and housing, the areas where families most often slide from help into harm without noticing.
Programs such as Community Reinforcement and Family Training (CRAFT) teach family members concrete skills for encouraging treatment entry without confrontation. Al-Anon and Nar-Anon offer peer support for the family side of the equation. Both are worth naming to families at intake.
Managing PAWS and the Anxiety Spike in Early Recovery
Post-acute withdrawal syndrome, or PAWS, is the cluster of lingering symptoms, anxiety, and sleep problems that can persist after acute withdrawal ends.
The practical reality: PAWS symptoms tend to come in waves, often worse in the first few months and tapering over time, though the timeline varies widely by substance and by person. Anxiety, irritability, low mood, sleep disruption, and difficulty concentrating are the most common complaints.
What helps during the PAWS window:
- Keep treatment contact steady. Dropping from several sessions a week to none is the setup for relapse; step down gradually instead.
- Protect sleep. Sleep disruption amplifies anxiety, and both are relapse triggers. Consistent wake times matter more than perfect sleep.
- Name the wave. When a bad day arrives, ask not “am I failing?” but “is this a PAWS wave, and what is my plan for the next 48 hours?”
Digital Tools That Extend Care Between Sessions
Telehealth sessions, recovery apps with check-in prompts, and online IOP formats keep treatment contact steady through the PAWS window, when motivation dips and schedules get hard. The advantage is not novelty; it is frequency. A daily check-in prompt reaches someone on a Tuesday night when a weekly appointment is four days away.
Useful categories to look for:
- Telehealth therapy for scheduled sessions with a licensed clinician, which most insurers now cover similarly to in-person care
- Recovery apps with craving tracking, mood logs, and peer check-ins, useful for pattern recognition, not a replacement for treatment
- Online IOP for structured multi-hour programming when transportation or scheduling is the barrier
Our family counseling services work alongside individual care for this reason: the household is part of the treatment picture, not a bystander.
Verify Your Insurance and Start With a Clinical Assessment
The first step is a clinical assessment, not a commitment to a program. An assessment tells you whether you are looking at anxiety alone, substance use alone, or both, and it points to the right level of care.
Insurance questions deserve straight answers before you start. Utah Family Therapy accepts insurance, and verifying benefits early tells you what your plan covers and what you’ll pay out of pocket, so there are no surprises later.
We also keep current openings.
Frequently Asked Questions
What is the most effective treatment for co-occurring anxiety and substance use disorders?
Integrated treatment is the approach with the strongest support. A 2023 review found that integrated behavioral treatments outperformed substance-use treatment alone on both substance-use and anxiety outcomes, with small-to-moderate effects favoring integrated care. In practice, that means one team addressing both conditions at once, combining cognitive behavioral therapy, motivational interviewing, and contingency management rather than sending you to two separate providers. SAMHSA describes its resources as evidence-based support for providers screening, diagnosing, and delivering integrated care to people with co-occurring disorders.
Why is it important to treat anxiety and addiction at the same time?
Treating only one side often leaves the other untreated and undermines recovery. A review by R. Kathryn McHugh and colleagues notes that anxiety disorders co-occur with substance use disorders at high rates in both the general population and treatment-seeking samples. SAMHSA’s summary of 2024 National Survey on Drug Use and Health data puts the number of adults with co-occurring mental illness and substance use disorder at roughly 21.2 million. When anxiety goes unaddressed, coping skills stay thin and relapse risk climbs, which is why integrated care targets both together.
How does integrated treatment for dual diagnosis work?
Integrated treatment means one care plan and one clinical team address the substance use disorder and the anxiety together. A psychiatric evaluation and structured screening come first, then therapy and any needed medication are coordinated rather than handled by separate providers who do not talk to each other. McHugh’s review points out that assessing anxiety when a substance use disorder is present is genuinely challenging, so careful clinical assessment matters. Integrated care also builds coping skills and relapse prevention around the anxiety triggers that drive use.
Can anxiety medications be used safely during substance use recovery?
Some medications, including certain antidepressants, are used in recovery, but the decision belongs to a qualified prescriber who knows your history. Benzodiazepines deserve particular caution because of dependence risk, and a clinician weighs that against the benefit. The research reviewed here does not establish one medication protocol for everyone, so treat any general claim with skepticism. A psychiatric evaluation is the right starting point, and medication decisions should be made alongside therapy rather than instead of it.
What are the signs of co-occurring anxiety and substance use disorders?
Common signs include drinking or using to calm racing thoughts, panic, or worry; needing more of a substance to get the same relief; anxiety that worsens during withdrawal; and avoidance of situations that trigger both fear and urges to use. McHugh and colleagues note that separating anxiety symptoms from substance-related symptoms takes careful assessment, since they overlap. If you notice this pattern in yourself or a family member, a clinical assessment is the appropriate next step rather than self-diagnosis.
How do intensive outpatient programs support dual diagnosis recovery?
Intensive outpatient programs for co-occurring disorders provide several treatment sessions each week while you continue living at home, which suits people who need more than weekly therapy but do not need residential care. Groups and individual sessions address anxiety symptoms and substance use in the same program, with relapse prevention and coping skills built in. For teens and young adults, scheduling flexibility matters so school and work can continue. Utah Family Therapy offers adolescent and adult IOPs and accepts insurance, so verifying coverage is a practical first step.
If you are trying to hold anxiety and substance use together on your own, the split is the problem, not you. Utah Family Therapy treats both conditions in one plan, with IOPs for teens and adults, in-person and online care, and clinicians who combine professional training with lived experience. Get started with Utah Family Therapy and begin with a clinical assessment that maps the right level of care for your family.
